Cargando...
Targeted intestinal delivery of incretin secretagogues—towards new diabetes and obesity therapies
A new strategy under development for the treatment of type 2 diabetes and obesity is to mimic some of the effects of bariatric surgery by delivering food-related stimuli to the distal gastrointestinal tract where they should enhance the release of gut hormones such as glucagon-like peptide-1 (GLP-1)...
Gardado en:
| Publicado en: | Peptides |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier Science Inc
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5805852/ https://ncbi.nlm.nih.gov/pubmed/29412834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.peptides.2017.11.008 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|